Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid (Cancer Chemotherapy and Pharmacology, (2025), 95, 1, (41), 10.1007/s00280-025-04749-w) Journal Article
| Authors: | Heldrup, J.; Bleyer, A.; Ramsey, L.; Schaff, L.; Bernhardt, B.; Schwartz, S.; Chatelut, E.; Hwang, M.; Ten, C.; Guscott, M. |
| Article Title: | Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid (Cancer Chemotherapy and Pharmacology, (2025), 95, 1, (41), 10.1007/s00280-025-04749-w) |
| Abstract: | The Editor-in-Chief has retracted this article because Fig. 1 and its legend contained data that was published without the owner’s permission or the patient’s consent. Figure 1 has now been removed. Jesper Heldrup, Stefan Schwartz, Etienne Chatelut, Miriam Hwang do not agree to this retraction. Archie Bleyer did not state explicitly whether they agree ot this retraction. Brooke Bernhardt agrees to this retraction. Laura Ramsey, Lauren Schaff, Carolina Ten, Martin Guscott and Scott Howard did not respond to correspondence from the Editor about this retraction. © 2025 Elsevier B.V., All rights reserved. |
| Keywords: | clinical article; controlled study; clinical trial; drug megadose; diagnosis; drug toxicity; phase 3 clinical trial; erratum; human; female |
| Journal Title: | Cancer Chemotherapy and Pharmacology |
| Volume: | 95 |
| Issue: | 1 |
| ISSN: | 03445704 |
| Publisher: | Elsevier B.V. |
| Date Published: | 2025-01-01 |
| Start Page: | 77 |
| Language: | English |
| DOI: | 10.1007/s00280-025-04798-1 |
| PUBMED: | 40711596 |
| PROVIDER: | scopus |
| PMCID: | PMC12296868 |
| DOI/URL: | |
| Notes: | Erratum -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work